| 2018-11-08 | Sale | Merck & Co., Inc. MRK | Exe V-P & Pres, MRL | 450,886 0.0139% | $60.12 | $27.11M | +9.27% | |
| 2012-02-02 | Sale | Amgen Inc. AMGN | EVP, Research & Development | 75,000 0.008% | $58.61 | $4.4M | +18.69% | |
| 2009-06-02 | Sale | Amgen Inc. AMGN | EVP, Research & Development | 85,000 0.0084% | $51.07 | $4.34M | +13.21% | |
| 2005-11-17 | Sale | Amgen Inc. AMGN | EVP, Research & Development | 100,000 0.008% | $82.38 | $8.24M | -13.73% | |
| 2005-08-27 | Sale | Amgen Inc. AMGN | EVP, Research & Development | 200 <0.0001% | $80.90 | $16,180 | ||
| 2005-07-27 | Sale | Amgen Inc. AMGN | EVP, Research & Development | 39,800 0.0032% | $81.05 | $3.23M | -7.76% | |
| 2003-07-31 | Sale | Amgen Inc. AMGN | EVP, Research & Development | 25,000 0.0011% | $38.36 | $959,000 | -12.36% |